GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ThermoGenesis Holdings Inc (STU:THR) » Definitions » Institutional Ownership

ThermoGenesis Holdings (STU:THR) Institutional Ownership : 0.14% (As of May. 24, 2024)


View and export this data going back to . Start your Free Trial

What is ThermoGenesis Holdings Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ThermoGenesis Holdings's institutional ownership is 0.14%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ThermoGenesis Holdings's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ThermoGenesis Holdings's Float Percentage Of Total Shares Outstanding is 88.36%.


ThermoGenesis Holdings Institutional Ownership Historical Data

The historical data trend for ThermoGenesis Holdings's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ThermoGenesis Holdings Institutional Ownership Chart

ThermoGenesis Holdings Historical Data

The historical data trend for ThermoGenesis Holdings can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 1.54 1.54 0.12 0.34 0.34 0.34 0.34 0.30 0.14 0.14

ThermoGenesis Holdings Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


ThermoGenesis Holdings (STU:THR) Business Description

Traded in Other Exchanges
Address
2711 Citrus Road, Rancho Cordova, CA, USA, 95742
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.